SENTHIL DAMODARAN to Receptors, Estrogen
This is a "connection" page, showing publications SENTHIL DAMODARAN has written about Receptors, Estrogen.
Connection Strength
0.535
-
Estrogen Receptor: A Paradigm for Targeted Therapy. Cancer Res. 2021 11 01; 81(21):5396-5398.
Score: 0.478
-
Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study. Int J Cancer. 2022 06 15; 150(12):2025-2037.
Score: 0.031
-
Phase II study of Radium-223 dichloride combined with hormonal therapy for hormone receptor-positive, bone-dominant metastatic breast cancer. Cancer Med. 2020 02; 9(3):1025-1032.
Score: 0.026